It is a link to move in the page.
To global navigation
To the text
To local navigation
To site information
Font Size
Language
news release
January 18, 2012
Bonalon Bag for I.V. Infusion 900 µg Approved as Japan’s First I.V. Drug for Osteoporosis
July 28, 2011
Febuxostat (FEBURIC®) Launches in Korea - Novel Drug for Treatment of Chronic Hyperuricemia in Gout Patients -
Archives
corporate profile
Message from the President
Corporate Profile
Overview of Core Business
Global Operations
Compliance
Organization
Corporate Social Responsibility(CSR)
Synergies of the Teijin Group
Research and Development
Customer and marketing support services
History
Office Locations
